首页> 外文期刊>Therapeutic Drug Monitoring >Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations.
【24h】

Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations.

机译:在使人免疫缺陷病毒失活所需的温度下加热人血清对游离苯妥英钠,游离丙戊酸和游离卡马西平浓度的测量的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

Minimizing the risk for infection to laboratory staff from a contaminated blood sample is a major safety goal in the clinical laboratory. One dangerous pathogen, the human immunodeficiency virus (HIV), can be deactivated by heating sera at 56 degrees C for 30 minutes. The authors previously reported that if serum was subjected to those conditions, the concentrations of the nine most commonly monitored drugs were not altered, whereas phenytoin and carbamazepine concentrations were reduced slightly. Monitoring free phenytoin, free valproic acid, and free carbamazepine concentrations is strongly recommended for patients with uremia, liver disease, and hypoalbuminemia. Because drug protein binding can be affected by temperature, the authors investigated the effect on free drug concentrations of sera heated to levels necessary for deactivation of the HIV virus. They measured total and free drug concentrations in serum pools prepared from patients receiving phenytoin, valproic acid, and carbamazepine. Serum pools were heated at 56 degrees C for 30 minutes and then brought to room temperature. The total and free drug concentrations were measured immediately after heating and then at 20- and 45-minute intervals. The concentrations of free phenytoin and free valproic acid were significantly higher after heat treatment. However, after equilibration of sera at room temperature for 20 minutes, the free concentrations of phenytoin were comparable to preheating values, although total phenytoin concentrations (Serum Separator Tubes) were reduced slightly. In contrast, free valproic acid concentrations did not return to the original levels even after 45 minutes. Free carbamazepine concentrations did not change even immediately after heating. However, total carbamazepine concentrations were reduced slightly when sera were heated in serum separator tubes (SST Tubes).
机译:使污染的血液样本对实验室工作人员的感染风险最小化是临床实验室的主要安全目标。一种危险的病原体,即人类免疫缺陷病毒(HIV),可以通过在56摄氏度下加热血清30分钟来使其失活。作者先前曾报道说,如果血清处于这些条件下,则最常监测的九种药物的浓度不会改变,而苯妥英和卡马西平的浓度则略有降低。对于尿毒症,肝病和低白蛋白血症的患者,强烈建议监测游离的苯妥英钠,游离的丙戊酸和游离的卡马西平浓度。由于药物蛋白的结合会受到温度的影响,因此作者研究了加热至血清使HIV病毒失活所需水平对血清游离药物浓度的影响。他们测量了从接受苯妥英钠,丙戊酸和卡马西平的患者制备的血清库中的总药物浓度和游离药物浓度。将血清池在56℃下加热30分钟,然后使其升至室温。加热后立即以20分钟和45分钟的间隔测量总和游离药物浓度。热处理后,游离苯妥英钠和游离丙戊酸的浓度明显更高。但是,在室温下平衡血清20分钟后,虽然总苯妥英钠浓度(血清分离管)略有降低,但苯妥英钠的游离浓度与预热值相当。相反,即使在45分钟后,游离丙戊酸浓度也未恢复到原始水平。甚至加热后,游离卡马西平的浓度也没有变化。但是,在血清分离管(SST管)中加热血清时,卡马西平的总浓度会略有降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号